These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3268061

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract] [Full Text] [Related]

  • 47. Novel use of continuous topical papaverine infusion delivered via a balloon pump to help maintain vascular patency in a case of intractable arterial spasm in a smoker.
    Song C, Por YC, Wong CH, Woo EK.
    J Plast Reconstr Aesthet Surg; 2008 Aug; 61(8):988-9. PubMed ID: 18436494
    [No Abstract] [Full Text] [Related]

  • 48. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
    Heidrich H, Meuche C, Ranft J, Rummel S, Peters A.
    Prog Clin Biol Res; 1989 Aug; 301():411-6. PubMed ID: 2678131
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
    Ranke C, Creutzig A, Alexander K.
    Med Klin (Munich); 1991 Jul 15; 86(7):349-52, 382. PubMed ID: 1921896
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Effect of prostaglandin E1 upon collateral vessels in peripheral occlusive arterial disease.
    Rudofsky G, Gerngross U.
    Prog Clin Biol Res; 1989 Jul 15; 301():407-9. PubMed ID: 2798455
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B, Lundberg G, Olsson A, Ostergren J.
    Vasa; 1986 Jul 15; 15(1):56-60. PubMed ID: 3962459
    [No Abstract] [Full Text] [Related]

  • 57. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A, Bruch HP, Hörl M, Düsel W.
    Prog Clin Biol Res; 1987 Jul 15; 242():439-44. PubMed ID: 2959966
    [Abstract] [Full Text] [Related]

  • 58. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 15; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 59. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 60. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.